Beta Bionics BBNX Income Statement (2023-2026)

NASDAQ BBNX
$20.13 +0.12 (+0.60%)
At close: Aug 20, 2026 · 10:16 AM UTC
Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter) 12.93M15.05M16.70M20.44M17.64M23.24M27.25M32.12M27.63M32.01M
Cost of Revenue (Quarter) 5.73M6.96M7.79M8.75M8.67M10.73M12.13M13.18M11.19M13.11M
Gross Profit (Quarter) 7.20M8.08M8.91M11.69M8.97M12.50M15.12M18.94M16.44M18.90M
Operating items
Research & Development (Quarter) 7.66M8.97M9.64M10.80M13.40M15.62M16.05M16.33M20.73M24.64M
Selling, General & Administrative (Quarter) 3.51M4.54M5.11M4.71M6.62M7.88M7.92M8.60M9.62M9.60M
Other Operating Expenses (Quarter) 5.48M6.35M5.14M9.21M7.59M8.87M8.20M10.13M10.36M10.24M
Operating Expenses (Quarter) 16.65M19.87M19.89M24.73M27.61M32.38M32.16M35.07M40.71M44.48M
Operating Income (Quarter) -9.45M-11.78M-10.98M-13.04M-18.64M-19.87M-17.04M-16.12M-24.27M-25.58M
EBIT (Quarter) -9.45M-11.78M-10.98M-13.04M-18.64M-19.87M-17.04M-16.12M-24.27M-25.58M
Non-operating items
Interest & Investment Income (Quarter) 1.14M0.99M0.83M0.95M2.44M3.00M2.83M2.66M2.38M2.18M
Other Non Operating Income (Quarter) 0.00M-0.00M-0.00M-0.00M0.00M-0.00M
Non Operating Income (Quarter) -3.00M-2.68M1.24M-5.07M-10.01M3.00M2.83M2.66M2.38M2.17M
Net income details
EBT (Quarter) -8.81M-11.29M-10.75M-12.69M-62.42M-60.71M-82.76M-14.27M-43.64M-64.36M
Profit After Tax (Quarter) -12.58M-14.49M-9.74M-18.10M-28.66M-16.96M-14.21M-13.47M-22.39M-23.70M
Income from Continuing Operations (Quarter) -8.81M-11.29M-10.75M-12.69M-62.42M-60.71M-82.76M-14.27M-43.64M-64.36M
Consolidated Net Income (Quarter) -8.81M-11.29M-10.75M-12.69M-62.42M-60.71M-82.76M-14.27M-43.64M-64.36M
Income towards Parent Company (Quarter) -8.81M-11.29M-10.75M-12.69M-62.42M-60.71M-82.76M-14.27M-43.64M-64.36M
Net Income towards Common Stockholders (Quarter) -8.81M-11.29M-10.75M-12.69M-62.42M-60.71M-82.76M-14.27M-43.64M-64.36M
Additional items
EPS (Basic) (Quarter) -1.46-1.85-1.61-1.99-2.03-1.40-1.90-0.35-0.98-1.44
EPS (Diluted) (Quarter) -1.46-1.85-1.61-1.99-2.03-1.40-1.90-0.35-0.98-1.44
Shares Outstanding (Quarter) 5.30M6.02M6.11M6.66M6.37M30.71M43.39M43.63M40.53M44.44M44.55M
Shares Outstanding (Diluted) (Quarter) 5.30M6.02M6.11M6.66M6.37M30.71M43.39M43.63M40.53M44.44M44.55M
Shares Outstanding (Entity) (Quarter) 6.02M6.02M6.66M6.66M6.67M30.71M43.47M43.99M44.36M44.56M44.98M
EBITDA (Quarter) -9.45M-11.78M-10.98M-13.04M-18.64M-19.87M-17.04M-16.12M-24.27M-25.58M
Interest Expenses (Quarter) 51.90M0.50M0.50M0.60M0.60M46.21M43.84M68.55M0.80M21.74M40.96M